Skip to main content
Erschienen in: European Radiology 2/2020

16.09.2019 | Oncology

Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI

verfasst von: Jie Chen, Zhenru Wu, Chunchao Xia, Hanyu Jiang, Xijiao Liu, Ting Duan, Likun Cao, Zheng Ye, Zhen Zhang, Ling Ma, Bin Song, Yujun Shi

Erschienen in: European Radiology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore the noninvasive prediction of hepatocellular carcinoma (HCC) with progenitor phenotype based on gadoxetic acid-enhanced magnetic resonance imaging (MRI).

Methods

This retrospective study included 115 surgery-proven HCCs with preoperative gadoxetic acid-enhanced MRI from August 2015 to September 2018. Image features were reviewed. Quantitative image analysis was performed using histogram analysis. HCC with progenitor phenotype was defined as positive for either cytokeratin 19 (CK19) or epithelial cell adhesion molecule (EpCAM) expression. Statistically significant variables for identifying HCCs with progenitor phenotype were determined at multivariate analyses. ROC analyses were used to determined cutoff values and the diagnostic performance of significant variables and combinations. Prediction nomogram was constructed based on multivariate analysis.

Results

At multivariate regression analyses, AFP ≥ 155.25 ng/mL (p < 0.001), skewness on T2WI ≤ 1.10 (p = 0.024), uniformity on pre-T1WI ≤ 0.91 (p = 0.024), irregular tumor margin (p = 0.006), targetoid appearance (p = 0.001), and the absence of mosaic architecture (p = 0.014) were significant predictors of HCCs expressing progenitor cell markers. Combing any three of those significant variables, it provides a diagnostic accuracy of 0.86 (95% CI 0.78–0.92) with sensitivity of 0.97 (95% CI 0.86–1.00), and specificity of 0.74 (95% CI 0.63–0.83). The C-index of the regression coefficient-based nomogram was 0.94 (95% CI 0.91–0.98).

Conclusions

Noninvasive prediction of HCCs with progenitor phenotype can be achieved with high accuracy by integrated interpretation of biochemical and radiological information, representing a handy tool for precise patient management and the prediction of prognosis.

Key Points

• Qualitative image features of irregular tumor margin, targetoid appearance, and the absence of mosaic architecture are significant predictors of hepatocellular carcinoma with progenitor phenotype.
• Quantitative analyses using whole-lesion histogram analysis provides additional information for the prediction of hepatocellular carcinoma with progenitor phenotype.
• Noninvasive prediction of hepatocellular carcinoma with progenitor phenotype can be achieved with high accuracy by integrated interpretation of clinical information and qualitative and quantitative imaging analyses.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30CrossRef Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30CrossRef
3.
Zurück zum Zitat Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207CrossRef Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207CrossRef
4.
Zurück zum Zitat Portolani N, Coniglio A, Ghidoni S et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243:229–235CrossRef Portolani N, Coniglio A, Ghidoni S et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243:229–235CrossRef
5.
Zurück zum Zitat Calderaro J, Couchy G, Imbeaud S et al (2017) Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol 67:727–738CrossRef Calderaro J, Couchy G, Imbeaud S et al (2017) Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol 67:727–738CrossRef
6.
Zurück zum Zitat Lo RC, Ng IO (2013) Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. Liver Cancer 2:84–92CrossRef Lo RC, Ng IO (2013) Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. Liver Cancer 2:84–92CrossRef
7.
Zurück zum Zitat Joo I, Kim H, Lee JM (2015) Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. Korean J Radiol 16:50–68CrossRef Joo I, Kim H, Lee JM (2015) Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. Korean J Radiol 16:50–68CrossRef
8.
Zurück zum Zitat Uenishi T, Kubo S, Yamamoto T et al (2003) Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 94:851–857CrossRef Uenishi T, Kubo S, Yamamoto T et al (2003) Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 94:851–857CrossRef
9.
Zurück zum Zitat Zhuang PY, Zhang JB, Zhu XD et al (2008) Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 112:2740–2748CrossRef Zhuang PY, Zhang JB, Zhu XD et al (2008) Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 112:2740–2748CrossRef
10.
Zurück zum Zitat Yamashita T, Forgues M, Wang W et al (2008) EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68:1451–1461CrossRef Yamashita T, Forgues M, Wang W et al (2008) EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68:1451–1461CrossRef
11.
Zurück zum Zitat Tan PS, Nakagawa S, Goossens N et al (2016) Clinicopathological indices to predict hepatocellular carcinoma molecular classification. Liver Int 36:108–118CrossRef Tan PS, Nakagawa S, Goossens N et al (2016) Clinicopathological indices to predict hepatocellular carcinoma molecular classification. Liver Int 36:108–118CrossRef
12.
Zurück zum Zitat Guan DX, Shi J, Zhang Y et al (2015) Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade. Hepatology 62:1791–1803CrossRef Guan DX, Shi J, Zhang Y et al (2015) Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade. Hepatology 62:1791–1803CrossRef
13.
Zurück zum Zitat Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS (2012) MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int 32:430–440PubMed Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS (2012) MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int 32:430–440PubMed
14.
Zurück zum Zitat Choi SY, Kim SH, Park CK et al (2018) Imaging features of gadoxetic acid-enhanced and diffusion-weighted MR imaging for identifying cytokeratin 19-positive hepatocellular carcinoma: a retrospective observational study. Radiology 286:897–908CrossRef Choi SY, Kim SH, Park CK et al (2018) Imaging features of gadoxetic acid-enhanced and diffusion-weighted MR imaging for identifying cytokeratin 19-positive hepatocellular carcinoma: a retrospective observational study. Radiology 286:897–908CrossRef
15.
Zurück zum Zitat Hu XX, Wang WT, Yang L et al (2019) MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas. Eur J Radiol 113:7–14CrossRef Hu XX, Wang WT, Yang L et al (2019) MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas. Eur J Radiol 113:7–14CrossRef
16.
Zurück zum Zitat Choi Y, Kim SH, Youn IK, Kang BJ, Park WC, Lee A (2017) Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: comparison with ER-positive subtype. PLoS One 12:e0177903CrossRef Choi Y, Kim SH, Youn IK, Kang BJ, Park WC, Lee A (2017) Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: comparison with ER-positive subtype. PLoS One 12:e0177903CrossRef
17.
Zurück zum Zitat Yuan M, Pu XH, Xu XQ et al (2017) Lung adenocarcinoma: assessment of epidermal growth factor receptor mutation status based on extended models of diffusion-weighted image. J Magn Reson Imaging 46:281–289CrossRef Yuan M, Pu XH, Xu XQ et al (2017) Lung adenocarcinoma: assessment of epidermal growth factor receptor mutation status based on extended models of diffusion-weighted image. J Magn Reson Imaging 46:281–289CrossRef
18.
Zurück zum Zitat Hu XX, Yang ZX, Liang HY et al (2017) Whole-tumor MRI histogram analyses of hepatocellular carcinoma: correlations with Ki-67 labeling index. J Magn Reson Imaging 46:383–392CrossRef Hu XX, Yang ZX, Liang HY et al (2017) Whole-tumor MRI histogram analyses of hepatocellular carcinoma: correlations with Ki-67 labeling index. J Magn Reson Imaging 46:383–392CrossRef
19.
Zurück zum Zitat Moriya T, Saito K, Tajima Y et al (2017) 3D analysis of apparent diffusion coefficient histograms in hepatocellular carcinoma: correlation with histological grade. Cancer Imaging 17:1CrossRef Moriya T, Saito K, Tajima Y et al (2017) 3D analysis of apparent diffusion coefficient histograms in hepatocellular carcinoma: correlation with histological grade. Cancer Imaging 17:1CrossRef
21.
Zurück zum Zitat Rhee H, Nahm JH, Kim H et al (2016) Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. Mod Pathol 29:1038–1049CrossRef Rhee H, Nahm JH, Kim H et al (2016) Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. Mod Pathol 29:1038–1049CrossRef
22.
Zurück zum Zitat Rhee H, An C, Kim HY, Yoo JE, Park YN, Kim MJ (2019) Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features. Liver Cancer 8:24–40CrossRef Rhee H, An C, Kim HY, Yoo JE, Park YN, Kim MJ (2019) Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features. Liver Cancer 8:24–40CrossRef
23.
Zurück zum Zitat Liu R, Shen Y, Nan K et al (2015) Association between expression of cancer stem cell markers and poor differentiation of hepatocellular carcinoma: a meta-analysis (PRISMA). Medicine (Baltimore) 94:e1306CrossRef Liu R, Shen Y, Nan K et al (2015) Association between expression of cancer stem cell markers and poor differentiation of hepatocellular carcinoma: a meta-analysis (PRISMA). Medicine (Baltimore) 94:e1306CrossRef
24.
Zurück zum Zitat Kudo M (2009) Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 44(Suppl 19):112–118CrossRef Kudo M (2009) Multistep human hepatocarcinogenesis: correlation of imaging with pathology. J Gastroenterol 44(Suppl 19):112–118CrossRef
25.
Zurück zum Zitat Li M, Xin Y, Fu S et al (2016) Corona enhancement and mosaic architecture for prognosis and selection between of liver resection versus transcatheter arterial chemoembolization in single hepatocellular carcinomas >5 cm without extrahepatic metastases: an imaging-based retrospective study. Medicine (Baltimore) 95:e2458CrossRef Li M, Xin Y, Fu S et al (2016) Corona enhancement and mosaic architecture for prognosis and selection between of liver resection versus transcatheter arterial chemoembolization in single hepatocellular carcinomas >5 cm without extrahepatic metastases: an imaging-based retrospective study. Medicine (Baltimore) 95:e2458CrossRef
26.
Zurück zum Zitat Cannella R, Furlan A (2018) Mosaic architecture of hepatocellular carcinoma. Abdom Radiol (NY) 43:1847–1848CrossRef Cannella R, Furlan A (2018) Mosaic architecture of hepatocellular carcinoma. Abdom Radiol (NY) 43:1847–1848CrossRef
27.
Zurück zum Zitat Yoneda N, Matsui O, Kobayashi S et al (2019) Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma. Jpn J Radiol 37:191–208CrossRef Yoneda N, Matsui O, Kobayashi S et al (2019) Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma. Jpn J Radiol 37:191–208CrossRef
28.
Zurück zum Zitat Locatelli E, Li Y, Monaco I et al (2019) A novel theranostic gold nanorods- and adriamycin-loaded micelle for EpCAM targeting, laser ablation, and photoacoustic imaging of cancer stem cells in hepatocellular carcinoma. Int J Nanomedicine 14:1877–1892CrossRef Locatelli E, Li Y, Monaco I et al (2019) A novel theranostic gold nanorods- and adriamycin-loaded micelle for EpCAM targeting, laser ablation, and photoacoustic imaging of cancer stem cells in hepatocellular carcinoma. Int J Nanomedicine 14:1877–1892CrossRef
Metadaten
Titel
Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI
verfasst von
Jie Chen
Zhenru Wu
Chunchao Xia
Hanyu Jiang
Xijiao Liu
Ting Duan
Likun Cao
Zheng Ye
Zhen Zhang
Ling Ma
Bin Song
Yujun Shi
Publikationsdatum
16.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06414-2

Weitere Artikel der Ausgabe 2/2020

European Radiology 2/2020 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.